Views & Analysis A new dawn for clinical trial management It’s time for pharma to take a 360-degree view of its clinical trial data and step into the future with near real-time trial management.
R&D Dangerous data delays – a real-time problem Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candid
R&D Is a lack of real-time data holding trials back? It’s 2020 and the digital revolution is well on its way.
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face